Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.
25 sept. 2019 21h11 HE
|
Atlas Blockchain Group Inc.
VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its...